Zoonotic & Vector-Borne Diseases

The nation’s top public health officials believes the disease is destined to spread across the United States in the coming months.

Despite public outcry, experts agree that vector-control methods are still the most effective ways to fight the spread of the Zika virus.

New cases of Zika are impacting Florida’s “Little Haiti” neighborhood.

Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses if Lyme disease poses a bigger threat than Zika virus in New Jersey.

The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.

With social media serving as a news source to so many, researchers from the Medical College of Wisconsin and the Tulane University School of Medicine studied how Facebook users are talking about the Zika virus.

New studies on the Zika virus have revealed how long the virus may stay in the vaginal tract, as UK researchers have mapped the first complete Zika virus genome derived from semen.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if the public should be concerned by avian influenza.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains how to combat anti-vaccine trends.

A new CDC study suggests that a closer look at the epidemiology of cat scratch disease may help prevent infections.

A mutated version of Yersinia pestis may hold the key to vaccines for the plague.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if the influenza vaccine can be administered to a patient with Zika.

Research groups from around the world have identified potential therapeutic targets for treating active Zika virus.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses Zika and sexual transmission.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses what is known about the study that found Zika virus in tears.

Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.

Researchers from the United Kingdom and Brazil have isolated the full-length genome sequence of the Zika virus.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if vertical transmission of Zika is cause for concern.

Researchers discuss five strategies to aid in the control of neglected tropical diseases.

Researchers review recent progress made on neglected tropical diseases since 2010.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if southern states will see more Zika infections.

Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, recommends how to reduce the risk of Lyme disease.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains what the CDC is doing about Zika.

A new Zika virus case cluster has emerged in Miami, according to the Florida Department of Health.

Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses whether the new Lyme-carrying bacteria, Borrelia mayonii, has different effects than Borrelia burgdorferi.